Ponatinib Interactions
There are 605 drugs known to interact with ponatinib, along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 182 are major, 396 are moderate, and 27 are minor.
- View all 605 medications that may interact with ponatinib
- View ponatinib alcohol/food interactions (1)
- View ponatinib disease interactions (5)
Most frequently checked interactions
View interaction reports for ponatinib and the medicines listed below.
- Acidophilus (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Alka-Seltzer Heartburn + Gas ReliefChews (calcium carbonate / simethicone)
- Allegra (fexofenadine)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- Aspirin Buffered (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide)
- Aspirin Lite Coat (aspirin)
- Atarax (hydroxyzine)
- Benadryl (diphenhydramine)
- Cialis (tadalafil)
- Coenzyme Q10 (ubiquinone)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Norvasc (amlodipine)
- Paracetamol (acetaminophen)
- Pepcid (famotidine)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Quercetin (bioflavonoids)
- Sprycel (dasatinib)
- Tasigna (nilotinib)
- Toprol-XL (metoprolol)
- Valtrex (valacyclovir)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
Ponatinib alcohol/food interactions
There is 1 alcohol/food interaction with ponatinib.
Ponatinib disease interactions
There are 5 disease interactions with ponatinib which include:
More about ponatinib
- ponatinib consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Tepezza
Tepezza (teprotumumab) infusion is used for thyroid eye disease (TED). Includes Tepezza side ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Hydroxyurea
Hydroxyurea systemic is used for cervical cancer, chronic myelogenous leukemia, glioblastoma ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.